Shanghai Opm Biosciences Stock Price To Book

688293 Stock   37.92  0.38  1.01%   
Shanghai OPM Biosciences fundamentals help investors to digest information that contributes to Shanghai OPM's financial success or failures. It also enables traders to predict the movement of Shanghai Stock. The fundamental analysis module provides a way to measure Shanghai OPM's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shanghai OPM stock.
Long Term DebtNet Debt18.9M9.8M12.9M22.4M20.1M17.9M100%
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Shanghai OPM Biosciences Company Price To Book Analysis

Shanghai OPM's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

 = 

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current Shanghai OPM Price To Book

    
  2.05 X  
Most of Shanghai OPM's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shanghai OPM Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Competition

Based on the latest financial disclosure, Shanghai OPM Biosciences has a Price To Book of 2.0488 times. This is 92.02% lower than that of the Biotechnology sector and 66.08% lower than that of the Health Care industry. The price to book for all China stocks is 78.46% higher than that of the company.

Shanghai Price To Book Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shanghai OPM's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Shanghai OPM could also be used in its relative valuation, which is a method of valuing Shanghai OPM by comparing valuation metrics of similar companies.
Shanghai OPM is currently under evaluation in price to book category among its peers.

Shanghai Fundamentals

Return On Equity0.0099
Return On Asset0.0035
Profit Margin0.07 %
Operating Margin0.29 %
Current Valuation3.1 B
Shares Outstanding113.55 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110%20%30%40%50%
Shares Owned By Insiders36.35 %
Shares Owned By Institutions42.94 %
Price To Book2.05 X
Price To Sales14.49 X
Revenue243.12 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3120%40%60%80%100%120%140%
Gross Profit297.24 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%
EBITDA64.62 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%
Net Income54.04 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%
Total Debt8.6 M
Book Value Per Share19.01 X
Cash Flow From Operations57.95 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%3,000%3,500%
Earnings Per Share0.33 X
Target Price53.41
Beta0.56
Market Capitalization4.31 B
Total Asset2.3 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%300%
Retained Earnings131.52 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%1,200%1,400%
Working Capital1.59 B
Annual Yield0.01 %
Net Asset2.3 B

About Shanghai OPM Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Shanghai OPM Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shanghai OPM using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shanghai OPM Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai OPM financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai OPM security.